Scholarlink

Purpose <p>This study aimed to evaluate the characteristics of congenital lung malformations (CLMs) in patients from infancy to adulthood, and to determine the optimal timing for thoracoscopic surgery.</p> Methods <p>All patients with CLMs who underwent thoracoscopic surgery between 2017 and 2023 were retrospectively reviewed. The patients were divided into five age groups: 1–6 months, 6–12 months, 1–4 years, 4–16 years, and &gt;16 years. Clinical characteristics and surgical outcomes were compared and analyzed for variance among the age groups.</p> Results <p>A total of 173 patients with CLM were included. Thirteen (7.5%) patients were categorized in the 1–6 months age group, 44 (25.4%) in the 6–12 months age group, 58 (33.5%) in the 1–4 years age group, 30 (17.3%) in the 4–16 years age group, and 28 (16.2%) in the &gt;&#xa0;16 years age group. The median age at surgery was 2.3 years (range: 1 month to 74 years). The operative time was shortest in the 1–4 years age group at 86.5 min (interquartile range: 57.3–131.5 min, <i>p</i> &lt; 0.01). The results of the multivariate regression analysis indicated that age &gt;&#xa0;4 years (odds ratio [OR]: 8.70, <i>p</i> &lt; 0.01) and previous infection (OR: 3.75, <i>p</i> &lt; 0.01) increased the risk of operative adhesions, which increased the risk of major complications and conversion to open thoracotomy.</p> <p><i>Conclusion</i>: Thoracoscopic surgery for CLMs is safe and feasible at all ages.&#xa0;Age &lt; 4 years&#xa0;may predict uneventful surgical outcomes due to fewer operative adhesions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Elective thoracoscopic surgery for congenital lung malformations: what age to operate?

  • 期刊论文

  • 发表日期：

    2025年1月30日

查看全文
  • Yuqing Zhao,
  • Dan Liu,
  • Yanan Wang,
  • Zhiyi Niu,
  • Huimin Jia,
  • Yuzuo Bai

摘要

Purpose

This study aimed to evaluate the characteristics of congenital lung malformations (CLMs) in patients from infancy to adulthood, and to determine the optimal timing for thoracoscopic surgery.

Methods

All patients with CLMs who underwent thoracoscopic surgery between 2017 and 2023 were retrospectively reviewed. The patients were divided into five age groups: 1–6 months, 6–12 months, 1–4 years, 4–16 years, and >16 years. Clinical characteristics and surgical outcomes were compared and analyzed for variance among the age groups.

Results

A total of 173 patients with CLM were included. Thirteen (7.5%) patients were categorized in the 1–6 months age group, 44 (25.4%) in the 6–12 months age group, 58 (33.5%) in the 1–4 years age group, 30 (17.3%) in the 4–16 years age group, and 28 (16.2%) in the > 16 years age group. The median age at surgery was 2.3 years (range: 1 month to 74 years). The operative time was shortest in the 1–4 years age group at 86.5 min (interquartile range: 57.3–131.5 min, p < 0.01). The results of the multivariate regression analysis indicated that age > 4 years (odds ratio [OR]: 8.70, p < 0.01) and previous infection (OR: 3.75, p < 0.01) increased the risk of operative adhesions, which increased the risk of major complications and conversion to open thoracotomy.

Conclusion: Thoracoscopic surgery for CLMs is safe and feasible at all ages. Age < 4 years may predict uneventful surgical outcomes due to fewer operative adhesions.